Skip to content

ADVANCED OXYGEN TECHNOLOGIES, INC.: 10-Q filed 2025-05-01

What ADVANCED OXYGEN TECHNOLOGIES, INC. reported in its quarterly report filed 2025-05-01 (fiscal Q3 2025): 30 published measures, 94 facts as tagged in accession 0001477932-25-003200.

This filing

Form
10-Q (quarterly report)
Filed
2025-05-01
Fiscal period
fiscal Q3 2025
Accession
0001477932-25-003200 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ADVANCED OXYGEN TECHNOLOGIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-03-31644,509USD
At 2024-06-30675,214USD
At 2024-03-31690,542USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-03-31291,459USD
At 2024-06-30333,277USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-03-31353,050USD
At 2024-12-31321,920USD
At 2024-06-30341,937USD
At 2024-03-31344,752USD
At 2023-12-31360,497USD
At 2023-06-30350,779USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-01-01 to 2025-03-312,818USD90
2024-07-01 to 2025-03-313,495USD274
2024-01-01 to 2024-03-312,520USD91
2023-07-01 to 2024-03-312,848USD275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-07-01 to 2025-03-3126,593USD274
2023-07-01 to 2024-03-3131,358USD275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-01-01 to 2025-03-3110,585USD90
2024-07-01 to 2025-03-3134,726USD274
2024-01-01 to 2024-03-3110,770USD91
2023-07-01 to 2024-03-3131,904USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-07-01 to 2025-03-31-64,010USD274
2023-07-01 to 2024-03-31-29,637USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-03-31-20,753,276USD
At 2024-06-30-20,756,771USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-01-01 to 2025-03-313,292,945shares90
2024-07-01 to 2025-03-313,292,945shares274
2024-01-01 to 2024-03-313,292,945shares91
2023-07-01 to 2024-03-313,292,945shares275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-01-01 to 2025-03-313,302,945shares90
2024-07-01 to 2025-03-313,302,945shares274
2024-01-01 to 2024-03-313,302,945shares91
2023-07-01 to 2024-03-313,302,945shares275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-01-01 to 2025-03-310USD/shares90
2024-07-01 to 2025-03-310USD/shares274
2024-01-01 to 2024-03-310USD/shares91
2023-07-01 to 2024-03-310USD/shares275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-01-01 to 2025-03-310USD/shares90
2024-07-01 to 2025-03-310USD/shares274
2024-01-01 to 2024-03-310USD/shares91
2023-07-01 to 2024-03-310USD/shares275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-01-01 to 2025-03-312,282USD90
2024-07-01 to 2025-03-317,527USD274
2024-01-01 to 2024-03-312,871USD91
2023-07-01 to 2024-03-316,902USD275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-03-31585,649USD
At 2024-06-30579,588USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-03-315,103USD90
2024-07-01 to 2025-03-3110,673USD274
2024-01-01 to 2024-03-315,391USD91
2023-07-01 to 2024-03-319,455USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-03-3158,860USD
At 2024-06-3095,626USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-03-31291,459USD
At 2024-06-30206,248USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-03-312,975USD
At 2024-06-301,050USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-01-01 to 2025-03-315,482USD90
2024-07-01 to 2025-03-3124,053USD274
2024-01-01 to 2024-03-315,379USD91
2023-07-01 to 2024-03-3122,449USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-03-313,292,945shares
At 2024-06-303,292,945shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-03-3157,705USD
At 2024-06-3094,482USD
At 2024-03-31105,239USD
At 2023-06-30104,836USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-03-3121,057,116USD
At 2024-06-3021,057,116USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2025-03-3116,231USD
At 2024-06-308,613USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2025-03-31127,029USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-01-01 to 2025-03-315,100USD90
2024-07-01 to 2025-03-3111,022USD274
2024-01-01 to 2024-03-315,391USD91
2023-07-01 to 2024-03-319,750USD275

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-01-01 to 2025-03-312,818USD90
2024-07-01 to 2025-03-313,495USD274
2024-01-01 to 2024-03-312,520USD91
2023-07-01 to 2024-03-312,848USD275

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-01-01 to 2025-03-3131,030USD90
2024-07-01 to 2025-03-3111,113USD274
2024-01-01 to 2024-03-31-15,745USD91
2023-07-01 to 2024-03-31-6,027USD275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-01-01 to 2025-03-311,482USD90
2024-07-01 to 2025-03-315,034USD274
2024-01-01 to 2024-03-311,379USD91
2023-07-01 to 2024-03-314,949USD275

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-3USD90
2024-07-01 to 2025-03-31349USD274
2024-01-01 to 2024-03-310USD91
2023-07-01 to 2024-03-31295USD275

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-07-01 to 2025-03-310USD274
2023-07-01 to 2024-03-31285USD275

Inspect the source

Entity
ADVANCED OXYGEN TECHNOLOGIES, INC. / CIK 0000352991
Captured
2026-09-19T14:57:13.072Z
SEC response SHA-256
5153194a6f819ef350892f1fe4b2a3d742337aaf701081ccd5803d9ace356acb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000352991.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))